latest news releases from the newsroom
Discovery Laboratories, Inc.
Discovery Laboratories Submits Marketing Authorization Application to Market Surfaxin(R)in Europe
DOYLESTOWN, Pa., Oct. 5, 2004 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that a Marketing Authorization Application (MAA) has been submitted to the European Medicines Evaluation Agency (EMEA) for clearance to market Surfaxin(R) in Europe for the treatment and prevention of Respiratory Distress Syndrome (RDS) in premature infants. Surfaxin is a novel, peptide-containing, humanized lung surfactant developed from Discovery's proprietary surfactant replacement technology platform.
Sunwin International Neutraceuticals, Inc.
Sunwin International Neutraceuticals, Inc. Enters Memorandum of Understanding to Export Low-Calorie Natural Sweetener to Japan
BOCA RATON, Fla., Oct. 5, 2004 (PRIMEZONE) -- Sunwin International Neutraceuticals, Inc. (OTCBB:SUWN), an industry leader in the distribution and manufacture of Chinese herbs, veterinary medicines and low calorie natural sweetener (beet sugar) in China, announced today it has entered into a Memorandum of Understanding with Tomen Corporation, a Japanese firm, to export natural sweetener (beet sugar) to Japan. Under the agreement, Tomen Corporation will import Sunwin's natural sweetener (beet sugar) in bulk and perform purification in Japan. Further, both firms will form a joint venture in China to produce and purify beet sugar in China.